Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

NCT00500500 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped Inability to recruit sufficient number of patients

Conditions

Interventions

Sponsor

Ipsen